|
Drug research 药品研究 All together now 大家齐心协力 Charities help Big Pharma 慈善机构协助大型制药公司 IT WAS once only drug firms that developed drugs. But this is changing. Take the case of theMichael J. Fox Foundation, a Parkinson s disease charity. On April 19th it announced that itwould pay for a clinical trial of a drug developed by Sanofi, a French pharmaceutical giant,that might treat the mental symptoms of the disease. 过去只有制药公司才开发药品，但这种情况正在改变。就拿Michael J. Fox基金会，一个帕金森病的慈善机构来说。此机构在4月19号宣布他们将为赛诺菲，法国的制药巨头，所研发的一种药物的临床试验买单，此药有可能用于治疗帕金森病的精神症状。 The deal is the latest sign of a broader shiftone that is driven by desperation. Patents onblockbuster drugs are expiring. Research and development have grown lessproductive, with billions of dollars yielding only a trickle of drugs. 这笔交易是产业萎靡所触发的转变的最新迹象。重磅药品的专利已开始失效。药品研发部门已不再那么多产，数十亿美金的投入只换来少许药品的诞生。 Some blame stringent regulators. Others grumble that big pharma firms are toobureaucratic. All agree that developing a new drug takes money andtime . Whatever the cause, a shortfall in R D has inspireda flood of new partnerships. | 
